| • | Acquired three HA manufacturers, i.e., Songjiang Factory, Shanghai Jianhua and Qisheng Biological. |
| • | Market in ophthalmology, orthopedics and general surgery |
| • | First generation dermal filler “Martrifill海薇“ was approved by NMPA and launched in |
| • | Listed on HKSE Main Board |
| • | Merged 6 intraocular lens-related companies and completed the whole industry chain presence of IOL from raw materials, R&D, production to sales |
| • | Listed on SSE Star Market |
| • | The first domestic hydrophilic aspheric IOL approved |
| • | New generation ophthalmic material “Optimum Infinite” was launched |
| • | Acquired Hangzhou Aijinglun and obtained refractive lens PRL (依镜） |
| • | Third generation dermal filler Hyalumatrix (海魅) approved |
| • | Expanded into the field of photoelectric equipment by acquiring JUVA |
| • | Invested in a botulinum toxin company, Eirion |
| • | Obtaining the exclusive right to distribute two OK lens brands in China. |
| • | Acquired Hebei Xinshikang to expand the soft contact lens market |
沪公网安备
31010502002061号
All Rights Reserved | Haohai Biological Technology | People's Republic of China Internet Medical Products Information Qualification Certificate | Certificate No: (Hu) – Non-Operative-2018-0079
Copyright © 2020-2024 All Rights Reserved Website by Globalquincy.com
Company Overview